Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten C Moe

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Nature Communications|May 30, 2023
Antibody blockade of Jagged1 attenuates choroidal neovascularizationTorleif Tollefsrud Gjølberg, Jonas Aakre Wik, Hanna Johannessen, et al.
PNAS Nexus|December 11, 2023
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal deliverySopisa Benjakul, Aina Karen Anthi, Anette Kolderup, et al.
Science Translational Medicine|October 15, 2020
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologicsMalin Bern, Jeannette Nilsen, Mattia Ferrarese, et al.
Nature Communications|May 1, 2025
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse modelsAina Karen Anthi, Anette Kolderup, Eline Benno Vaage, et al.
The New England Journal of Medicine|January 28, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery OcclusionStephen J Ryan, Øystein Kalsnes Jørstad, Mona Skjelland, et al.
European Stroke Journal|June 13, 2025
Tenecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): Protocol for a randomized-controlled trialStephen J Ryan, Øystein Kalsnes Jørstad, Mona Skjelland, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Nature Communications|May 30, 2023
Antibody blockade of Jagged1 attenuates choroidal neovascularizationTorleif Tollefsrud Gjølberg, Jonas Aakre Wik, Hanna Johannessen, et al.
PNAS Nexus|December 11, 2023
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal deliverySopisa Benjakul, Aina Karen Anthi, Anette Kolderup, et al.
Science Translational Medicine|October 15, 2020
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologicsMalin Bern, Jeannette Nilsen, Mattia Ferrarese, et al.
Nature Communications|May 1, 2025
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse modelsAina Karen Anthi, Anette Kolderup, Eline Benno Vaage, et al.
The New England Journal of Medicine|January 28, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery OcclusionStephen J Ryan, Øystein Kalsnes Jørstad, Mona Skjelland, et al.
European Stroke Journal|June 13, 2025
Tenecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): Protocol for a randomized-controlled trialStephen J Ryan, Øystein Kalsnes Jørstad, Mona Skjelland, et al.
Pageof 9